Literature DB >> 17768553

[The ocular components in anisometropia].

David Tayah1, Vinicius Coral-Ghanem, Milton Ruiz Alves.   

Abstract

PURPOSE: To asses the correlation between ocular components (axial length, anterior segment length, corneal power, vitreous length and equivalent power of the eye) and refractive error in eyes with higher and lower ametropia of subjects with anisometropia.
METHODS: An analytical survey was carried out in 68 patients with anisometropia of two or more diopters, assisted at the Ophthalmological Clinic from "Hospital das Clínicas da Faculdade de Medicina" of São Paulo University. All participants were submitted to ophthalmologic examination which included objective and subjective cycloplegic refratometry, keratometry and ultrasonic biometry.
RESULTS: No significant difference between measures of ocular components of the eyes with higher and lower ametropias was observed. The eyes with lower ametropia presented the same significant correlations observed in emmetropic eyes: of refraction with anterior segment length and axial length, and of the axial length with corneal power and vitreous length. The eyes with higher ametropia presented significant correlation of refraction with the axial length and of the axial length with vitreous length. Furthermore, we observed in both eyes, significant correlation of the power of the crystalline lens with the anterior chamber depth.
CONCLUSION: The eyes with lower ametropia presented correlations more frequently observed in emmetropia. The eyes with higher ametropia did not present the same correlations observed in emmetropic eyes.

Entities:  

Mesh:

Year:  2007        PMID: 17768553     DOI: 10.1590/s0004-27492007000300013

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  1 in total

1.  Similarity of eyes in a cataractous population-How reliable is the biometry of the fellow eye for lens power calculation?

Authors:  Achim Langenbucher; Nóra Szentmáry; Alan Cayless; Veronika Röggla; Christina Leydolt; Jascha Wendelstein; Peter Hoffmann
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.